Digital PET/CT with 18F-FACBC in early castration-resistant prostate cancer: our preliminary results
Sign Up to like & getrecommendations! Published in 2022 at "Expert Review of Medical Devices"
DOI: 10.1080/17434440.2022.2117612
Abstract: ABSTRACT Background We assessed the role of digital PET/CT (dPET/CT) with 18F-FACBC in patients affected by castration-resistant prostate cancer with PSA levels ≤ 3 ng/mL (early CRPC), no lesions detectable at cross-sectional imaging (CIM) and… read more here.
Keywords: dpet; digital pet; prostate cancer; 18f facbc ... See more keywords
Detection Rate and Clinical Impact of PET/CT with 18F-FACBC in Patients with Biochemical Recurrence of Prostate Cancer: A Retrospective Bicentric Study
Sign Up to like & getrecommendations! Published in 2022 at "Biomedicines"
DOI: 10.3390/biomedicines10010177
Abstract: Our aim was to assess the detection rate (DR) of positron emission computed tomography (PET/CT) with anti-1-amino-3-[18F]-flurocyclobutane-1-carboxylic acid (18F-FACBC) in patients with biochemical recurrence (BCR) from prostate cancer (PC). As a secondary endpoint, we evaluated… read more here.
Keywords: recurrence; 18f facbc; prostate; detection rate ... See more keywords
Histomolecular Validation of [18F]-FACBC in Gliomas Using Image-Localized Biopsies
Sign Up to like & getrecommendations! Published in 2024 at "Cancers"
DOI: 10.3390/cancers16142581
Abstract: Simple Summary Gliomas are the most common type of malignant brain tumors in adults. They are frequently heterogeneous, containing regions of varying properties and aggressiveness. It can be challenging to define the tumor borders and… read more here.
Keywords: tumor tissue; tumor; facbc pet; 18f facbc ... See more keywords